The role of oxidative stress in HIV disease

Free Radical Biology and Medicine

Volumn 19, Issue 4, 1995, Pages 523-528

  Pace, Gary W ^a   Leaf, Cynthia D ^b  

^a Triangle Pharmaceuticals   (United States)

^b Free Radical Sciences Inc ^*  (United States)

Author keywords

AIDS; Free radicals; Glutathione; Human immunodeficiency virus; Oxidative stress

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; ACETYLCYSTEINE; ASCORBIC ACID; CAROTENOID; FREE RADICAL; GLUTATHIONE; MALONALDEHYDE; SELENIUM; SUPEROXIDE DISMUTASE; TOCOPHEROL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; CELL PROLIFERATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE FUNCTION TEST; IMMUNOCOMPETENT CELL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; VIRUS REPLICATION; WEIGHT REDUCTION;

ANTIOXIDANTS; HIV; HIV INFECTIONS; HUMAN; OXIDATIVE STRESS; VIRUS REPLICATION;

EID: 0029162485     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(95)00047-2     Document Type: Article

References (93)

1. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals
2. Antioxidant status and STD in migrants from subSaharian African countries
3. Blood deficiency of antioxidant status and polyunsaturated fatty acids as possible risk factors in the onset and development of AIDS
4. Total glutathione concentration in plasma of infected patients and HIV disease progression
5. Glutathione concentrations in plasma and blood are markedly decreased in HIV-infected children
6. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients
7. Imbalance between oxidants and antioxidants in the lungs of HIV-seropositive individuals
8. Glutathione deficiency in human HIV infection
9. Analysis of glutathione levels in whole blood of HIV-seropositive persons
10. Intracellular glutathione levels in T-cell subsets decrease in HIV-infected individuals
11. CD4 and CD8 T-cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses
12. Glutathione and immunophenotypes of T and B lymphocytes in HIV-infected individuals
13. Metabolic disorder as early consequence of simian immunodeficiency virus infection in rhesus macaques
14. Glutathione deficiency and human immunodeficiency virus infection
15. Cysteine and glutathione deficiency in AIDS patients: A rationale for the treatment with N-acetyl-cysteine
16. Selenium in the maintenance and therapy of HIV-infected patients
17. Selenium deficiency in HIV infection and the acquired immune deficiency syndrome (AIDS)
18. Antioxidant status and lipid peroxidation in patients infected with HIV
19. Oxidative imbalance in HIV infected patients
20. Betacarotene in HIV infection
21. Selenium deficiency in the acquired immune deficiency syndrome
22. −) production and enzymatic disbalance in peripheral blood cells isolated from HIV-infected children
23. The HIV-1 Tat protein represses Mn-superoxide dismutase expression in HeLa cells
24. Progressive increases in serum catalase activity in advancing human immunodeficiency virus infection
25. Lipid peroxidation in human immunodeficiency virus infection
26. Increased production of malondialdehyde in patients with HIV infection
27. Oxygen radical release by neutrophils of HIV-infected patients
28. Lipid peroxidation: Its mechanism, measurement, and significance
29. Increased resting energy expenditure in human immunodeficiency virus-infected men
30. Resting energy expenditure is increased in stable, malnourished HIV-infected patients
31. Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage
32. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
33. Resting energy expenditure in human immunodeficiency virus-infected patients: Comparison between patients with and without secondary infections
34. Role of free radicals and catalytic metal ions in human disease: An overview
35. Oxidative imbalance in HIV infected patients
36. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD
37. 2 generation by xanthine oxidase of pathogenesis of influenza virus infection in mice
38. Autotoxicity and reactive oxygen in viral disease
39. An inducible transcription factor activates expression of human immunodeficiency virus in T-cells
40. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kB transcription factor
41. Intracellular thiols regulate activation of nuclear factor kB and transcription of human immunodeficiency virus
42. NF-kB: A pleiotropic mediator of inducible and tissue-specific gene control
43. 4 transcriptionally activates interleukine-6 expression involving NK-kB and NF-IL6
44. Regulation of the transcription factors NF-kB and AP-1 by redox changes
45. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-l-cysteine
46. Inhibition of HIV-1 replication and NF-kB activity by cysteine and cysteine derivatives
47. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine
48. Comparative study of the anti-HIV activities of ascorbate and thiol-containing reducing agents in chronically HIV-infected cells
49. Lipoic acid is a potent inhibitor of NF-kB activation in human T cells
50. Procysteine inhibits TNF-a induced HIV production in U 1 cells
51. L-2 oxothiazolidine-4-carboxylate (Procysteine) inhibits HIV-1 expression but not interleukin-2 secretion
52. Influence of redox status on HIV transcription and replication
53. Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication
54. Elevation of glutathione levels by phase II enzyme inducers: Lack of inhibition of human immunodeficiency virus type 1 replication in chronically infected monocytoid cells
55. Glutathione: Its role in modulation of immune function
56. The B lymphocyte: A newly recognized source of reactive oxygen species with immunoregulatory potential
57. The generation of oxygen radicals A positive signal for lymphocyte activation
58. Glutathione metabolism in activated human neutrophils: Stimulation of glutathione synthesis and consumption of glutathione by reactive oxygen species
59. Impaired immunity in AIDS
60. The effect of cytokines and pharmacological agents on chronic HIV infection
61. Lymphocyte proliferation in glutathione-depleted lymphocytes: Direct relationship between glutathione availability and the proliferative response
62. Changes in intracellular glutathione levels in stimulated and unstimulated lymphocytes in the presence of 2-mercaptoethanol or cysteine
63. Radioprotection of human lymphoid cells by exogenously supplied glutathione is mediated by gamma-glutamyl transpeptidase
64. The effect of changes in thiol subcompartments on T-cell colony formation and cell cycle progression: Relevance to AIDS
65. N-acetylcysteine enhances T cell functions and T cell growth in culture
66. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens
67. Thiol-mediated redox regulation of lymphocyte proliferation
68. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
69. The cytopathic effect of HIV is associated with apoptosis
70. Programmed death of T cells in HIV-1 infection
71. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis
72. Programmed cell death and AIDS: From hypothesis to experiment
73. Oxidative stress and apoptosis in HIV infection: A role for plant-derived metabolites with synergistic antioxidant activity
74. N-acetyl-cysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells
75. HIB gene expression enhances T cell susceptibility to hydrogen peroxide-induced apoptosis
76. An antioxidant prevents apoptosis and early cell death in lymphocytes from HIV-infected individuals
77. Malnutrition in HIV infection and AIDS
78. The HIV wasting syndrome: A review
79. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS
80. Nutritional aspects of AIDS
81. Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection
82. Hypermetabolism in HIV-infected patients-A question of body composition?
83. Hypertrigyceridemia in the acquired immunodificiency syndrome
84. The wasting syndrome: Pathophysiology and treatment
85. Development of a novel glutathione repleting agent, L-2-oxothiazolidine-4-carboxylic acid
86. Allergic manifestations of human immonodeficiency virus (HIV) infection
87. Severe hepatotoxicity in a patient receiving both acetaminophen and zidovudine
88. Sulfonamide toxicity in HIV infection
89. Adverse reactions to co-trimoxazole in HIV infection
90. Inhibition of glutathione synthesis in the newborn rat: A model for endogenously produced oxidative stress
91. Glutathione depletion enhances bacterial translocation and alters immunological status
92. Renal disease and AIDS
93. Liver disease and AIDS